ArticleEuropean heart journal. Cardiovascular pharmacotherapy2023

Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy.

Robert A Sykes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.